Novo Holdings' CEO Kasim Kutay made the remarks while speaking to a group of journalists at the investment company's headquarters in Copenhagen.
Novo Holdings holds 28.1% of economic (or A) shares and 76.9% of voting (or B) shares in the Denmark's Novo Nordisk.
Novo, the drugmaker, is riding a wave of record profits from its new weight-loss and diabetes drugs, Wegovy and Ozempic. Its share price has roughly tripled over the past four years
https://finance.yahoo.com/news/novo-holdings-ceo-says-ipo-093945663.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.